Finished reading? Continue your journey in AI with these hand-picked guides and tutorials.
Boost your workflow with our browser-based tools
Share your expertise with our readers. TrueSolvers accepts in-depth, independently researched articles on technology, AI, and software development from qualified contributors.
TrueSolvers is an independent technology publisher with a professional editorial team. Every article is independently researched, sourced from primary documentation, and cross-checked before publication.
AMD struck a deal with Meta that could hand the social media giant 10% ownership of the chipmaker for pocket change. The transaction, valued between $60 billion and $100 billion depending on deployment scale, gives Meta the right to purchase 160 million AMD shares at one penny each. This isn't vendor financing or a customer discount. It's a fundamental shift in how chip companies fund explosive AI infrastructure growth, and it comes with significant risks that most coverage overlooks.
On February 24, 2026, AMD announced a multi-year agreement with Meta Platforms to supply up to 6 gigawatts of AI computing capacity starting in the second half of 2026. The hardware package includes a custom AMD Instinct GPU built on the MI450 architecture and optimized specifically for Meta's workloads, sixth-generation EPYC Venice server processors, AMD's ROCm software stack, and the Helios rack-scale platform co-developed by AMD and Meta through the Open Compute Project. Every element of that hardware arrangement is straightforward procurement. The warrant attached to it is not.
AMD issued Meta a performance-based warrant to purchase up to 160 million shares of AMD common stock at an exercise price of $0.01 per share. AMD's total outstanding shares sit at approximately 1.63 billion. One hundred and sixty million shares represents just under 10% of that total. At AMD's pre-announcement closing price of roughly $197 per share, those shares carry a market value of approximately $31.5 billion. Meta's cost to exercise the warrant in full: $1.6 million. That is not a typo.
The gap between $1.6 million and $31.5 billion is not a pricing error or a negotiating concession. It is the entire point. AMD is not offering Meta a discount on chips. It is offering Meta equity ownership of AMD itself, denominated in conditions rather than cash, at a strike price that makes the transaction functionally equivalent to a grant. AMD's stock climbed approximately 7 to 9 percent on the day of the announcement, adding more than $20 billion in market capitalization before the dilution math fully registered with investors.
Five months before the Meta announcement, AMD deployed an identical warrant structure with OpenAI. The SEC disclosures are explicit on the terms. The template is not improvised; it is deliberate.
The warrant does not vest automatically. Calling it a giveaway misses the architecture. AMD built a dual-track condition system where Meta must satisfy deployment milestones and AMD must satisfy stock price thresholds before any shares change hands.
The deployment track works in tranches. The first tranche vests when Meta deploys the initial 1 gigawatt of custom MI450 GPUs in the second half of 2026. Additional tranches unlock progressively as Meta's purchases scale toward the full 6-gigawatt commitment. Each tranche also requires Meta to clear certain technical and commercial conditions tied to deploying AMD hardware at scale, not just signing purchase orders.
The stock price track escalates in parallel. Each successive tranche requires AMD's share price to cross a higher threshold, with the final tranche vesting only if AMD reaches $600 per share. At the time of the announcement, AMD was trading near $197. The $600 threshold requires AMD's stock to roughly triple. If AMD never reaches that level, those final shares never vest, regardless of how much hardware Meta deploys.
Both the Meta warrant and the OpenAI warrant signed in October 2025 carry expiry dates: Meta's runs through February 23, 2031; the OpenAI warrant through October 5, 2030. Any unvested shares at expiry cancel automatically.
AMD's own SEC filing for the OpenAI deal states explicitly that the warrant was intended as "a material inducement for OpenAI to enter into the Supply Agreement." The company chose that language deliberately. It is an acknowledgment that the hardware deal required a financial incentive beyond pricing to close.
Asked directly about the risk to existing shareholders, an AMD spokesperson told The Register: the warrants are "completely performance-based, AMD must do well, and our shareholders must do well in order for these warrants to vest including our stock price being at $600/share at the last vest." That defense is substantively correct. It is also incomplete, and the incompleteness matters.
AMD signed two structurally identical deals, same 6-gigawatt scope, same 160-million-share warrant, same $0.01 strike price, same $600 final vesting threshold, with the two most prominent AI customers in the world within five months of each other. That is not coincidence. AMD has formalized equity-based procurement as deliberate competitive strategy. The open question is whether the template stops at two deals or whether the next hyperscaler to negotiate a large GPU purchase will expect the same terms.
The deal's financial logic depends on whether the revenue and earnings it generates justify the equity AMD is distributing. On paper, the numbers work.
AMD CEO Lisa Su has stated that each gigawatt of deployed AI compute represents double-digit billions in revenue for AMD. Bank of America analyst Vivek Arya put more precise figures around that framing: each gigawatt of deployment generates approximately $15 to $20 billion in revenue and roughly $6 billion in net income for AMD, with EPS accretion of approximately 13 to 23 percent by 2030, translating to roughly $25 in EPS power even after accounting for 10% dilution from the Meta warrant. At 6 gigawatts, the deal's total revenue potential sits between $90 billion and $100 billion over the agreement's lifetime.
Context makes that range more striking. AMD's entire 2025 net revenue, across all products, was $34.6 billion, a 34 percent year-over-year increase. The Meta deal alone could represent more than two years of AMD's current total revenue, spread over five years of deployment. AMD's Data Center segment, which hit $16.6 billion in 2025, would receive a step-change in scale if even half the deployment proceeds as planned.
The equity AMD distributes is partially self-financing: the revenue the deal generates supports AMD's stock performance, which in turn drives the warrant value, but AMD collects the revenue regardless of whether Meta ever exercises the warrant. Analyst reaction treats the deal as broadly accretive even with dilution factored in, and that logic explains why.
One manufacturing detail reinforces the deal's margin profile. AMD CFO Jean Hu confirmed that the custom MI450 variant built for Meta required no additional tape-out during the current MI400 design cycle. AMD did not pay extra tooling or development costs to customize the chip. The work was done at the chip, board, and system level starting from Meta's actual workload requirements, but within the existing manufacturing window. That means AMD is not absorbing custom chip development costs on top of the equity it is distributing.
AMD's stated financial targets for the next three to five years are built around this kind of deal. The company is targeting 35% compound annual growth and over $20 in earnings per share within that window, projecting $120 billion in AI revenue from what it views as a $1 trillion total AI market by the end of the decade.
The scale of this competition extends well beyond the AMD-Meta relationship. Meta's push for personal superintelligence infrastructure is running in parallel with rival bets across the industry, including Jeff Bezos's Project Prometheus, a $6.2 billion AI infrastructure commitment targeting a distinct approach to the same race for compute dominance. AMD's ability to secure gigawatt-scale commitments from Meta positions it across multiple fronts of that contest simultaneously.
The warrant structure makes more sense when viewed through the lens of what AMD is competing against, not just what it is selling.
Nvidia controls approximately 90% of the AI GPU market, with a valuation of roughly $4.66 trillion at the time of the announcement. AMD's market capitalization at the same point sat at approximately $320 billion. The hardware gap between Nvidia's and AMD's best AI accelerators has narrowed considerably in recent generations, but the hardware gap was never the primary obstacle to AMD winning large-scale enterprise deployments.
CUDA is. Nvidia's software ecosystem, built over nearly two decades, is deeply embedded in how AI developers write, optimize, and deploy models. Thousands of frameworks, libraries, and tooling pipelines assume CUDA at the foundation. AMD's ROCm is a genuine alternative, and it has matured substantially, but AMD's ROCm software stack still lags Nvidia's CUDA ecosystem in broad developer workflow compatibility. A customer considering a shift toward AMD hardware is not making a hardware procurement decision; it is making a software migration commitment that carries real operational risk.
Creative Strategies analyst Ben Bajarin described Meta's situation as "compute constrained" meaning that access to processing capacity, not budget, is what limits Meta's ability to build and deploy AI systems. That framing matters because it clarifies why Meta is buying from Nvidia, AMD, and building custom silicon simultaneously rather than standardizing on one vendor. For AMD, landing a gigawatt-scale commitment from a compute-constrained customer doing multi-vendor procurement is a genuine win, but it required a structure that reduced Meta's financial risk for betting on AMD's ecosystem.
The warrant functions less as a customer discount and more as a hedge against ROCm adoption uncertainty. AMD cannot eliminate the software switching cost through hardware engineering. What it can do is make the financial consequences of that switching risk more tolerable for the customer, by tying a share of AMD's equity upside to the customer's deployment success. If AMD's chips and software deliver at scale, both parties benefit. If they don't, Meta's warrant value declines in parallel with AMD's stock, but Meta has not made an irrecoverable software commitment.
The concern that surfaces most often in commentary about the AMD warrant structure is dilution: if Meta and OpenAI both exercise their warrants in full, existing AMD shareholders face approximately 20% dilution from 320 million new shares entering the float. That concern is real, but it is also the least near-term of the risks the structure creates.
The more immediate exposure is gross margin compression. Goldman Sachs analyst Sur warned that the warrant structure could reduce AMD's gross margins by 200 to 400 basis points on revenue tied to these deals. The mechanism is straightforward: warrants issued in exchange for procurement commitments are economically equivalent to a volume discount, except that the discount is paid in equity rather than cash. AMD books the revenue at full price, but shareholders absorb the dilutive cost as a separate line item. That compression begins when chips start shipping in H2 2026, well before any warrant shares vest.
The broader circular financing concern AMD issues equity to Meta, Meta deploys AMD chips, deployments drive AMD's stock, AMD's stock inflates the warrant value, and that value finances more chip procurement is a real dynamic in the AI infrastructure ecosystem. Goldman Sachs and Morgan Stanley have both flagged the increasing circularity of AI-related financial relationships as a systemic concern across the sector.
The circular financing risk here is more bounded than sector-level commentary suggests. Analyst Ian Cutress identified a structural feature that reframes the dilution concern: if all 160 million warrant shares vest and Meta sells them at $600 per share, the proceeds total approximately $96 billion, roughly matching the hardware deal's total revenue potential. This symmetry is not accidental. AMD designed the warrant so that if its stock reaches $600 meaning AMD has executed on its AI roadmap and shareholders have been richly rewarded Meta's equity gain approximates what Meta spent on AMD hardware. The deal self-finances at precisely the moment it dilutes most.
That reframing does not eliminate the risk. It redefines it. Maximum dilution and maximum shareholder value creation are the same event in this structure. The scenario where the deal goes badly for shareholders AMD stock stagnating, chips underperforming, hardware revenue failing to materialize is the same scenario where the warrant never fully vests. Dilution risk and execution risk are not separate concerns here; they are the same concern.
Most coverage of the AMD-Meta deal treats it as an accomplished milestone, a validated strategy, and a signal about AMD's competitive trajectory. All of that may ultimately prove true. But there is a number in AMD's own financial disclosures that changes how to interpret everything above.
As of December 27, 2025, none of the OpenAI warrant shares had met vesting or exercise conditions. Not a single share had vested from the October 2025 OpenAI deal by the time AMD closed its fiscal year. The entire value proposition of AMD's chips-for-equity model the revenue projections, the EPS accretion, the competitive realignment against Nvidia remains entirely prospective.
This matters because of how the market received the Meta announcement. AMD's stock rose approximately 7 to 9 percent on February 24. Analysts raised price targets. The narrative that AMD had executed a transformational deal went largely unquestioned. In a technical sense, AMD had announced a deal. It had not yet delivered one. The first real test of whether the structure works is the initial 1-gigawatt MI450 shipment in the second half of 2026. That shipment triggers the first warrant tranche. It also triggers the first meaningful revenue recognition. Until that happens, the deal exists as a set of mutual commitments rather than a set of financial outcomes.
AMD's 2025 full-year net revenue of $34.6 billion and its Data Center segment's record year are genuine accomplishments that demonstrate the company's growth trajectory. But they reflect the period before these deals begin contributing. The next twelve months are when the model gets tested at scale.
The AMD spokesperson's defense of the warrant structure that both AMD and its shareholders must do well for warrants to vest is accurate and, in the abstract, reassuring. What it does not address is the execution requirement embedded in that logic. For AMD to benefit from these deals, it needs to deliver MI450 at gigawatt scale on the timelines it has committed to, with ROCm performance that satisfies Meta's and OpenAI's deployment requirements, in a market where Nvidia retains its software and supply chain advantages. None of that is impossible. None of it is certain.
If AMD's stock never reaches $600, do Meta and OpenAI get nothing?
Not exactly. The warrants vest in tranches, and only the final tranche requires AMD's stock to reach $600. Earlier tranches vest at lower stock price thresholds alongside deployment milestones. A scenario where AMD's stock remains flat but Meta deploys the first few gigawatts of MI450 GPUs would likely result in partial warrant vesting at lower thresholds. Meta and OpenAI would receive some equity; they just would not receive the full 160 million shares each deal authorizes. The $600 threshold governs the final, largest tranche.
How does combined 20% dilution affect AMD's existing shareholders in practice?
The dilution is gradual, contingent, and spread over five years. No shares have vested yet. Full 20% dilution from both deals requires AMD to deploy 12 gigawatts of GPUs across two major customers and reach a stock price of $600 per share. If those conditions are met, AMD's market capitalization at the $600 per share level would be approximately $1 trillion or higher, meaning existing shareholders would own a smaller percentage of a dramatically larger company. Bank of America's projection 13 to 23 percent EPS accretion by 2030 even after accounting for 10% dilution from the Meta deal alone suggests the dilution's economic impact on per-share earnings is positive at full deployment scale, assuming the revenue materializes.